Adagene Inc. (ADAG) Social Stream



Adagene Inc. (ADAG): $2.55

0.04 (+1.59%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add ADAG to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#27 of 363

in industry

ADAGENE INC (ADAG) Price Targets From Analysts

Use the tables below to see what analysts covering ADAGENE INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-12 2 $40.57 $33 $35.523 $3.09 1049.61%
2021-12-07 2 $40.57 $30 $34.523 $3.09 1017.25%
2022-01-06 2 $40.57 $27 $32.523 $3.09 952.52%
2022-01-31 1 $40.57 $15 $28.523 $3.09 823.07%
2022-04-12 2 $40.57 $15 $27.19 $3.09 779.94%
2022-10-12 2 $26 $7 $16.5 $3.09 433.98%
2022-12-05 2 $26 $7 $16.5 $3.09 433.98%
2022-12-07 3 $26 $5 $12.666 $3.09 309.9%
2023-03-29 3 $26 $5 $12 $3.09 288.35%
2023-09-01 3 $5 $5 $5 $3.09 61.81%
2023-12-19 3 $5 $4.6 $4.8 $3.09 55.34%

The Trend in the Analyst Price Target


ADAG's average price target has moved down $22.39 over the prior 21 months.

Over the past 47 weeks, ADAG's average upside potential has been 377.7%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-24 3 26 5.0 12.0 1.84 552.17%
2023-03-29 3 26 5.0 12.0 1.51 694.7%
2023-04-03 2 5 5.0 5.0 1.35 270.37%
2023-09-01 3 5 5.0 5.0 1.38 262.32%
2023-12-19 3 5 4.6 4.8 1.48 224.32%

ADAG Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


ADAG's average broker recommendation rating improved by 0.5 over the prior 20 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADAG as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, ADAGENE INC's number of analysts covering the stock is greater than 59.31% of them.
  • ADAG has a greater upside potential (average analyst target price relative to current price) than 1256.12% of all US stocks.
  • ADAGENE INC's variance in analysts' estimates is lower than -596.7% of Healthcare stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, ADAGENE INC's average analyst price target is higher than 689.12% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ADAGENE INC are LGVN, CNTB, and LVTX.

Is ADAG a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!